Pulse PubMed Daily Triage Digest — 2026-08-02

Run: 2026-08-02 | Attempt 1 | Generated 09:00 UTC Articles included: 32 total — 9 DEEP_DIVE | 17 MONITOR | 6 WATCH HIGH priority: 18 | MEDIUM: 13 | LOW: 1 Topics with no results: cbc_diagnostics_ml (0 hits both primary and fallback queries)

🔴 DEEP DIVE (score 8–10)

9/10 — Tissue Memory Score captures proximal tubular identity loss and independently stratifies survival in clear cell renal cell carcinoma.

PMID: 42542400 | Journal: Urologic Oncology | Topics: sentinel_scan, precision_oncology Authors: Khalil S, Hamdan M Study design: Multi-cohort retrospective validation (TCGA-KIRC n=540; CPTAC-3 and E-MTAB-1980 external cohorts; random-effects meta-analysis) Key finding: TMS independently associates with OS in ccRCC (HR 0.595/SD; P=6.6e-5), improves discrimination over stage (delta-C-index 0.0189), replicates in two external cohorts, and separates 5-year survival by 17.3 pp by TMS tertile in stage II-III disease.

TMS scores a tumor proximity to normal kidney tissue in a PCA space of 2,694 GTEx healthy samples; higher scores denote retained proximal tubular identity and better prognosis independently of stage, purity, and mutational burden. External validation in CPTAC-3 and E-MTAB-1980 and concordant results across platforms support prospective evaluation for post-nephrectomy ccRCC risk stratification. Triage reason: Novel biologically anchored prognostic biomarker with three-cohort external validation for the most common kidney cancer; platform-robust and ready for prospective evaluation; directly actionable for risk stratification.

8/10 — Future Trends in Cancer Prevention and Interception in Cancer Predisposition Syndromes: Leveraging Insights From High-Risk Populations.

PMID: 42538617 | Journal: International Journal of Cancer | Topics: early_cancer_detection_liquid_biopsy, precision_oncology Authors: Wang Y, Malkin D, Lipkin SM Study design: Narrative review with synthesis of RCTs, population studies, and phase I/II trial data Key finding: Liquid biopsy can detect malignancies before radiologic findings in CPS patients; immunoprevention neoantigen vaccines in MMR-deficient tumors show preliminary immunogenicity; metformin in Li-Fraumeni and aspirin in Lynch syndrome demonstrate cancer risk modification in clinical studies.

This review from Hospital for Sick Children and Weill Cornell synthesizes genomic advances enabling earlier CPS diagnosis including newborn TP53 R337H screening in Brazil. Novel cancer interception strategies spanning liquid biopsy surveillance, neoantigen vaccines, and chemoprevention create a paradigm shift from detection to prevention in hereditary cancer syndromes. Triage reason: Directly relevant to liquid biopsy and early cancer detection watchlist; covers actionable interception strategies across Li-Fraumeni, Lynch, and other major CPS; high-impact International Journal of Cancer publication.

8/10 — Real-world evaluation of the effectiveness and safety of tirzepatide in patients with obesity: a prospective study.

PMID: 42542297 | Journal: Clinical Nutrition ESPEN | Topics: cardiovascular_metabolic Authors: Perez-Pevida B, Santana Santana M, Liano Arriola Cet al. Study design: Prospective longitudinal observational cohort (n=107, 6 months) Key finding: Tirzepatide achieved mean 18.04 kg (17.21%) weight loss at 6 months; 95.35% achieved >=5% and 60.47% >=15% weight loss at median dose 7.5 mg; significant glycaemic and lipid improvements; 3.7% dropout rate.

Prospective real-world study of 107 Spanish patients confirms tirzepatide dual GIP/GLP-1 agonism translates beyond RCT settings, with substantial weight loss at maintenance doses lower than maximum approved. Comprehensive cardiometabolic benefits and favorable tolerability profile across comorbidity subgroups support routine clinical use. Triage reason: Real-world prospective confirmation of tirzepatide efficacy with comprehensive cardiometabolic outcomes; n=107, prospective design; directly watchlist-relevant for GLP-1/GIP, cardiometabolic.

8/10 — Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions.

PMID: 42542457 | Journal: Diabetologia | Topics: cardiovascular_metabolic Authors: Kahl S, Caussy C, Cusi K Study design: Critical systematic reappraisal with structured evidence synthesis (cross-sectional, longitudinal studies, and trial data) Key finding: MASLD functions as a risk enhancer rather than independent risk factor for diabetic micro- and macrovascular complications; most available evidence has critical limitations including inadequate control for shared cardiometabolic risk factors and heterogeneous study designs.

Top-tier Diabetologia analysis from German Diabetes Center, INSERM Lyon, and University of Florida reframes MASLD as a complication risk enhancer in T2D rather than independent causative factor, cautioning clinical over-attribution of vascular risk. The review identifies key knowledge gaps and calls for prospective studies with serial liver and complication assessments and rigorous confounder control. Triage reason: High-impact Diabetologia critical review reframing MASLD-diabetes complication relationship from leading centers; directly relevant to cardiometabolic watchlist; immediately actionable for clinical risk stratification of MASLD patients.

8/10 — Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain.

PMID: 42541517 | Journal: Familial Cancer | Topics: precision_oncology Authors: Bringas M, Echavarria I, Polo Cet al. Study design: Retrospective observational cohort (n=223 patients, 5-year real-world experience 2019-2024) Key finding: Mainstream germline testing in 223 pancreatic cancer patients found 14.3% pathogenic variant rate; 50% of PV carriers did not meet family history criteria; actionable mutations in 43.7% of PV carriers (BRCA2, PALB2, ATM) led to treatment modifications in 3% of all patients.

Streamlined mainstream genetic testing without specialist pre-counseling enabled rapid germline results (median 48 days) and identified BRCA2, PALB2, and ATM variants in 6.3% of all tested pancreatic cancer patients. The finding that half of PV carriers would be missed using traditional family history referral criteria directly challenges standard precision oncology gatekeeping practices. Triage reason: Precision oncology impact for high-unmet-need pancreatic cancer; demonstrates actionable variants missed by standard family-history criteria; directly informs PARP inhibitor and platinum-based therapy eligibility.

8/10 — MCT4-mediated lactate efflux promotes STING-dependent dendritic cell antitumor immunity.

PMID: 42541722 | Journal: Cell Reports | Topics: novel_therapeutics Authors: Ding R, Yuan Y, Xu Tet al. Study design: Mechanistic laboratory study with in vitro and in vivo models (Cell Reports, Nanjing Medical University) Key finding: MCT4-mediated lactate efflux from tumor cells activates the STING pathway in dendritic cells, creating a novel metabolic-immune coupling mechanism that promotes antitumor DC immunity; targeting MCT4 represents a new approach to enhancing immunotherapy efficacy.

Cell Reports study from Nanjing Medical University identifies MCT4 as the conduit linking tumor lactate metabolism to innate immune activation via STING in dendritic cells, establishing an immunometabolic checkpoint previously unrecognized in the tumor microenvironment. This axis may explain differential immunotherapy responsiveness across tumor types with varying lactate export profiles and suggests MCT4 inhibition as a strategy to amplify immune checkpoint therapy. Triage reason: High-impact Cell Reports mechanistic discovery of MCT4-STING-DC axis; novel targetable mechanism relevant to immunotherapy combination strategies; directly addresses tumor metabolic immunosuppression watchlist.

8/10 — Hepatectomy After Progressive Disease Following Chemotherapy for Colorectal Liver Metastases: A Japanese Nationwide Cohort Study.

PMID: 42542513 | Journal: Annals of Surgical Oncology | Topics: sentinel_scan Authors: Kobayashi K, Kishi Y, Yonamine Net al. Study design: Nationwide retrospective cohort study (Japan, multiple centers) Key finding: Hepatectomy after chemotherapy progression for colorectal liver metastases is oncologically viable in selected patients; nationwide Japanese cohort data define patient subgroups where salvage surgery improves outcomes despite chemo-failure, challenging conventional exclusion of these patients from surgical consideration.

This Japanese nationwide cohort study addresses salvage hepatectomy for colorectal liver metastases after chemotherapy progressive disease, providing population-level real-world data from multiple centers. Results support a nuanced surgical selection approach for chemo-refractory patients, with implications for improving multidisciplinary team decision-making in this high-unmet-need oncologic scenario. Triage reason: Nationwide cohort data on controversial surgical scenario in colorectal liver metastases; Annals of Surgical Oncology publication; directly actionable for precision selection of patients for salvage surgery.

8/10 — Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications.

PMID: 42542430 | Journal: International Journal of Gynecological Cancer | Topics: sentinel_scan, precision_oncology Authors: Nardelli P, Leitner K, Carrot Aet al. Study design: Multi-center retrospective cohort with mathematical kinetic modeling Key finding: Mathematical modeling of longitudinal HE4 kinetics during platinum-based chemotherapy in recurrent advanced ovarian carcinoma identifies early trajectory patterns with independent prognostic implications, enabling dynamic response monitoring beyond single-timepoint biomarker measurement.

This multi-center study applies mathematical modeling to serial HE4 measurements in recurrent advanced ovarian carcinoma, demonstrating that kinetic trajectory patterns carry prognostic information beyond absolute values or single timepoints. Modeling-derived signatures may enable earlier identification of platinum responders and non-responders, guiding adaptive treatment decisions in this high-unmet-need recurrent setting. Triage reason: Novel quantitative kinetic biomarker approach in high-unmet-need recurrent ovarian cancer; multi-center data with mathematical modeling; Int J Gynecol Cancer publication from established gynecologic oncology group.

8/10 — Latitude, Seasonality, and Circadian Determinants of Outcomes of Systemic Cancer Therapy: Evidence from Chemotherapy, Immunotherapy, and Chemo-Immunotherapy Combinations. A Systematic Review.

PMID: 42542197 | Journal: Critical Reviews in Oncology/Hematology | Topics: novel_therapeutics Authors: Ghidini A, Roncari L, Bukovec Ret al. Study design: PRISMA 2020 systematic review (n=35 studies: 6 RCTs, 2 patient-level meta-analyses, 5 prospective cohorts, 22 retrospective cohorts) Key finding: Morning/early daytime ICI administration associated with longer OS/PFS in retrospective cohorts; chronomodulated chemotherapy consistently reduced toxicity and sometimes improved response/TTP; vitamin D supplementation during immunotherapy associated with improved survival; objective circadian disruption repeatedly associated with poorer prognosis.

This PRISMA-guided systematic review of 35 studies including 6 RCTs finds time-of-day ICI administration and chronomodulated chemotherapy influence both efficacy and toxicity of systemic cancer therapy across tumor types. While ICI timing evidence remains hypothesis-generating, chronomodulated chemotherapy from historical RCTs and vitamin D-immunotherapy interactions warrant prospective evaluation for pragmatic clinical implementation. Triage reason: Systematic review with RCT-level evidence on modifiable variable (treatment timing, vitamin D) affecting immunotherapy outcomes; Crit Rev Oncol/Hematol; immediately actionable chronotherapy-ICI hypothesis for prospective testing.

🟡 MONITOR (score 6–7)

7/10 — AI-enabled chest x-ray potentially detects subclinical diastolic dysfunction in diabesity ... PMID 42542549 | Cardiovascular Diabetology and Endocrinology Reports | HIGH | Topics: ai_ml_diagnostics_imaging, cardiovascular_metabolic AI-enabled chest X-ray pulmonary venous hypertension staging detected subclinical diastolic dysfunction in all 15 diabesity patients pre-therapy; post-incretin therapy, significant weight-loss responders showed stable-decreased dysfunction while non-responders (80%) showed increased dysfunction, suggesting AI-CXR as a non-invasive cardiac monitoring tool for incretin therapy.

7/10 — Identification and validation of Parkinson's disease relevant microRNAs in plasma extracel... PMID 42541533 | Neurological Sciences | HIGH | Topics: aging_longevity_population_health Plasma extracellular vesicle-derived microRNAs are identified and validated as Parkinson's disease biomarkers, providing a minimally invasive liquid biopsy approach to PD diagnosis that may enable earlier detection of neurodegeneration before clinical symptoms become pronounced.

7/10 — A comprehensive analysis of the incidence of chromosomal abnormalities in hematologic mali... PMID 42541207 | Asian Biomedicine | HIGH | Topics: hematologic_malignancies COVID-19 pandemic did not substantially affect the incidence, cytogenetic profiles, or demographics of hematologic malignancies (leukemia, lymphoma, bone marrow disorders) over 2018-2024 in a large Thai academic center; except for a transient CLL chromosomal abnormality rise in 2023, no new or recurring patterns emerged.

7/10 — Forecasting the prevalence of epilepsy in low- and middle-income countries to 2050 using a... PMID 42541262 | Military Medical Research | HIGH | Topics: ai_ml_diagnostics_imaging, aging_longevity_population_health A hybrid DNN-transformer model trained on GBD 2023 data forecasts epilepsy prevalence trends to 2050 in LMICs, identifying country-specific burden trajectories and potentially informing resource allocation and intervention planning for this high-burden neurological condition.

7/10 — En-bloc Resection of Bladder Tumor Versus Conventional Transurethral Resection of Bladder ... PMID 42542426 | European Urology Focus | HIGH | Topics: sentinel_scan En-bloc resection of bladder tumor (ERBT) demonstrates comparable or superior long-term oncological outcomes versus conventional TURBT in this single-center prospective trial, providing evidence for ERBT as a standard surgical option for non-muscle-invasive bladder cancer.

7/10 — Safety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms. PMID 42541759 | European Journal of Endocrinology | HIGH | Topics: cardiovascular_metabolic GLP-1 receptor agonists can be used safely in neuroendocrine neoplasm (NEN) patients, addressing a critical safety concern given the rapidly expanding use of GLP-1/GIP agonists in patients who may have concurrent NEN diagnoses or be at elevated NEN risk.

7/10 — A clinical decision support system for predicting drug-related adverse effects in pediatri... PMID 42541705 | Journal of International Medical Research | HIGH | Topics: ai_ml_diagnostics_imaging Hybrid CDSS combining Random Forest (AUROC 0.902 on FDA FAERS) with expert rule-based engine achieved mean accuracy 0.85 across 11 drug-adverse effect pairs in 330 pediatric CHD inpatients, outperforming standalone ML and rule-based approaches for predicting drug-related adverse effects.

7/10 — Tertiary lymphoid structure transcriptomic signatures show limited and cohort-dependent va... PMID 42542556 | Anti-Cancer Drugs | HIGH | Topics: sentinel_scan, precision_oncology Tertiary lymphoid structure (TLS) transcriptomic signatures show limited and highly cohort-dependent predictive value for axillary lymph node involvement in ER+/luminal breast cancer, challenging the assumption that TLS signatures are robust pan-cohort biomarkers for nodal spread in this subtype.

7/10 — A Dynamic Prognostic and Adaptive Treatment Framework for Advanced Biliary Tract Cancer. PMID 42542210 | JHEP Reports | HIGH | Topics: ai_ml_diagnostics_imaging, precision_oncology A dynamic AI-enabled prognostic and adaptive treatment decision framework for advanced biliary tract cancer integrates real-time clinical, radiologic, and biomarker data to guide treatment adaptation, demonstrating improved prognostic accuracy over static models in multi-center validation.

6/10 — Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in... PMID 42541678 | Clinical Pharmacokinetics | MEDIUM | Topics: hematologic_malignancies, novel_therapeutics Exposure-response analysis of epcoritamab (CD20xCD3 bispecific antibody) in R/R follicular lymphoma defines optimal monotherapy dosing regimen, with exposure directly linked to both efficacy (objective response rate) and safety (CRS grade), supporting fixed-dose optimization for this indication.

6/10 — Molecular characteristics and advances in precision therapeutics for HR-positive and HER2-... PMID 42539411 | Frontiers in Oncology | MEDIUM | Topics: early_cancer_detection_liquid_biopsy, precision_oncology, novel_therapeutics HR+/HER2-low breast cancer (~60% of breast cancer incidence) represents an important precision oncology subtype; ADC deruxtecan significantly improved prognosis and reshaped the treatment landscape; integration of ctDNA liquid biopsy with digital pathology and NGS improves dynamic monitoring and treatment selection.

6/10 — Machine learning-based prediction of Clavien-Dindo >=II complications after ureteroscopy. PMID 42541663 | International Urology and Nephrology | MEDIUM | Topics: ai_ml_diagnostics_imaging Binomial GLM with Elastic Net (AUC 0.893) and gradient boosting model (AUC 0.857) both demonstrated excellent discrimination for Clavien-Dindo >=II complications after ureteroscopy using routinely available perioperative variables; operative time and impacted stones were key predictors.

6/10 — Reframing the value of reserve antibiotics: how ultra-orphan reimbursement pathways could ... PMID 42541082 | Health Policy Open | MEDIUM | Topics: rare_diseases_high_unmet_need Reserve antibiotics share key characteristics with ultra-orphan drugs (small high-need patient populations, significant clinical benefit uncertainty, value beyond clinical trial endpoints); ultra-orphan reimbursement pathways with higher prices and flexibility for clinical uncertainty could address the market failure driving inadequate antibiotic pipeline development.

6/10 — Cross-species functional analysis of a de novo DCLK1 variant associated with a neurodevelo... PMID 42539103 | Research Square (Preprint) | MEDIUM | Topics: rare_diseases_high_unmet_need De novo DCLK1 p.S228L variant causes severe locomotor deficits and aberrant neuronal morphology in C. elegans and neurite defects in patient-derived neurons; wild-type DCLK1 or pharmacological targeting of a downstream dysregulated pathway partially rescued neurite defects, implicating DCLK1 in a previously unrecognized progressive neurodevelopmental disorder.

6/10 — International survey on immunological diagnostics in children with sepsis. PMID 42539516 | Intensive Care Medicine: Paediatric and Neonatal | MEDIUM | Topics: rare_diseases_high_unmet_need International survey reveals significant heterogeneity in immunological diagnostic practices for pediatric sepsis across centers, identifying critical gaps in standardization that impede timely identification of immunological phenotypes and endotypes with implications for precision treatment of high-mortality pediatric infections.

6/10 — Clinical impact of salvage hepatectomy for local recurrence of hepatocellular carcinoma af... PMID 42542508 | International Journal of Clinical Oncology | MEDIUM | Topics: sentinel_scan Salvage hepatectomy for locally recurrent hepatocellular carcinoma after RFA or TACE demonstrates oncological viability with acceptable perioperative outcomes, providing comparative data to support surgical decision-making for HCC local recurrence after locoregional therapies.

6/10 — Associated factors regarding systemic anticancer therapy use prior to death among patients... PMID 42541969 | Lung Cancer | MEDIUM | Topics: novel_therapeutics 37% of metastatic NSCLC patients received systemic anticancer therapy in the final 6 weeks of life; prior hospitalization was independently associated with late SACT use (OR 2.673; P=0.006); patients receiving late SACT were significantly more likely to die in hospital (44.1% vs 9.6%).

🟢 WATCH (score 4–5)

5/10 — The eco-evolutionary dynamics of acute myeloid leukemia: From clonal games to cl... PMID 42542075 | Cancer Treatment and Research Communications | Topics: hematologic_malignancies

5/10 — Sodium Overload-Related Molecular Subtypes and a Four-Gene Prognostic Signature ... PMID 42541488 | Molecular Carcinogenesis | Topics: hematologic_malignancies, precision_oncology

5/10 — Primary bone lymphoma: a radiologic-pathologic series of 72 cases uncovering the... PMID 42542494 | Skeletal Radiology | Topics: hematologic_malignancies

5/10 — Past achievements and future perspectives of personalized vaccines and the role ... PMID 42541646 | Immunological Research | Topics: precision_oncology, novel_therapeutics

5/10 — Intratumoral Microbiota in Cancer: Spatial Evidence, Biological Mechanisms, and ... PMID 42542213 | Progress in Biophysics and Molecular Biology | Topics: novel_therapeutics

4/10 — Clinical characterization of cutaneous mucormycosis in patients receiving Bruton... PMID 42542351 | Enfermedades Infecciosas y Microbiologia Clinica | Topics: hematologic_malignancies

📊 Per-Topic Coverage Summary

ℹ️ Run Notes

• T2 (CBC/ML): Both primary and fallback queries returned 0 results for crdt 2026-08-01 to 2026-08-02. No coverage for this topic today.
• Preprint flagging: PMID 42539103 (DCLK1 NDD, Research Square) scored conservatively per protocol; scores capped at 6.
• Crossover articles: Several articles appear in multiple topic arrays (e.g., 42542549 in AI/ML + cardiovascular; 42538617 in early detection + precision oncology).
• Schema: v1.3 — four-axis score breakdown (novelty_relevance max 3, design_quality max 2, population_or_unmet_need max 2, evidence_maturity max 3); sum verified for all 32 articles.